Antibodies toward infliximab are associated with low infliximab concentration at treatment initiation and poor infliximab maintenance in rheumatic diseases

INTRODUCTION: A proportion of patients receiving infliximab have antibodies toward infliximab (ATI), which are associated with increased risk of infusion reaction and reduced response to treatment. We studied the association of infliximab concentration at treatment initiation and development of ATI...

Descripción completa

Detalles Bibliográficos
Autores principales: Ducourau, Emilie, Mulleman, Denis, Paintaud, Gilles, Miow Lin, Delphine Chu, Lauféron, Francine, Ternant, David, Watier, Hervé, Goupille, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218920/
https://www.ncbi.nlm.nih.gov/pubmed/21708018
http://dx.doi.org/10.1186/ar3386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218920/
https://www.ncbi.nlm.nih.gov/pubmed/21708018
http://dx.doi.org/10.1186/ar3386

Ejemplares similares